Literature DB >> 20501861

Berries and ellagic acid prevent estrogen-induced mammary tumorigenesis by modulating enzymes of estrogen metabolism.

Harini S Aiyer1, Ramesh C Gupta.   

Abstract

To determine whether dietary berries and ellagic acid prevent 17beta-estradiol (E(2))-induced mammary tumors by altering estrogen metabolism, we randomized August-Copenhagen Irish rats (n = 6 per group) into five groups: sham implant + control diet, E(2) implant + control diet (E(2)-CD), E(2) + 2.5% black raspberry (E(2)-BRB), E(2) + 2.5% blueberry (E(2)-BB), and E(2) + 400 ppm ellagic acid (E(2)-EA). Animals were euthanized at early (6 wk), intermediate (18 wk), and late (24 wk) phases of E(2) carcinogenesis, and the mammary tissue was analyzed for gene expression changes using quantitative real-time PCR. At 6 weeks, E(2) treatment caused a 48-fold increase in cytochrome P450 1A1 (CYP1A1; P < 0.0001), which was attenuated by both BRB and BB diets to 12- and 21-fold, respectively (P < 0.001). E(2) did not alter CYP1B1 levels, but both berry and EA diets significantly suppressed it by 11- and 3.5-fold, respectively, from baseline (P < 0.05). There was a 5-fold increase in 17beta-hydroxysteroid dehydrogenase 7 (17betaHSD7), and this was moderately abrogated to approximately 2-fold by all supplementation (P < 0.05). At 18 weeks, CYP1A1 was elevated by 15-fold in E(2)-CD and only E(2)-BB reduced this increase to 7-fold (P < 0.05). Catechol-O-methyltransferase expression was elevated 2-fold by E(2) treatment (P < 0.05), and all supplementation reversed this. At 24 weeks, CYP1A1 expression was less pronounced but still high (8-fold) in E(2)-treated rats. This increase was reduced to 3.2- and 4.6-fold by E(2)-BRB and E(2)-EA, respectively (P < 0.05), but not by E(2)-BB. Supplementation did not alter the effect of E(2) on steroid receptors. The diets also significantly suppressed mammary tumor incidence (10-30%), volume (41-67%), and multiplicity (38-51%; P < 0.05). Berries may prevent mammary tumors by suppressing the levels of E(2)-metabolizing enzymes during the early phase of E(2) carcinogenesis. 2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20501861      PMCID: PMC2896023          DOI: 10.1158/1940-6207.CAPR-09-0260

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  47 in total

1.  Ovary-intact, but not ovariectomized female ACI rats treated with 17beta-estradiol rapidly develop mammary carcinoma.

Authors:  J D Shull; T J Spady; M C Snyder; S L Johansson; K L Pennington
Journal:  Carcinogenesis       Date:  1997-08       Impact factor: 4.944

2.  Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities.

Authors:  Mar Larrosa; Antonio González-Sarrías; María Teresa García-Conesa; Francisco A Tomás-Barberán; Juan Carlos Espín
Journal:  J Agric Food Chem       Date:  2006-03-08       Impact factor: 5.279

Review 3.  Dual role of oestrogens as hormones and pro-carcinogens: tumour initiation by metabolic activation of oestrogens.

Authors:  J G Liehr
Journal:  Eur J Cancer Prev       Date:  1997-02       Impact factor: 2.497

Review 4.  Functional role of estrogen metabolism in target cells: review and perspectives.

Authors:  B T Zhu; A H Conney
Journal:  Carcinogenesis       Date:  1998-01       Impact factor: 4.944

5.  Cytochromes CYP1A1 and CYP1B1 in the rat mammary gland: cell-specific expression and regulation by polycyclic aromatic hydrocarbons and hormones.

Authors:  M Christou; U Savas; S Schroeder; X Shen; T Thompson; M N Gould; C R Jefcoate
Journal:  Mol Cell Endocrinol       Date:  1995-11-30       Impact factor: 4.102

6.  Predominant 4-hydroxylation of estradiol by constitutive cytochrome P450s in the female ACI rat liver.

Authors:  A M Wilson; G A Reed
Journal:  Carcinogenesis       Date:  2001-02       Impact factor: 4.944

Review 7.  Is estradiol a genotoxic mutagenic carcinogen?

Authors:  J G Liehr
Journal:  Endocr Rev       Date:  2000-02       Impact factor: 19.871

8.  Genetic control of estrogen action in the rat: mapping of QTLs that impact pituitary lactotroph hyperplasia in a BN x ACI intercross.

Authors:  James D Shull; Cynthia M Lachel; Clare R Murrin; Karen L Pennington; Beverly S Schaffer; Tracy E Strecker; Karen A Gould
Journal:  Mamm Genome       Date:  2007-09-18       Impact factor: 2.957

9.  Characterization of estrogen-dependent growth of cultured MCF-7 human breast-cancer cells expressing 17beta-hydroxysteroid dehydrogenase type 1.

Authors:  M M Miettinen; M H Poutanen; R K Vihko
Journal:  Int J Cancer       Date:  1996-11-27       Impact factor: 7.396

10.  Role of polymorphic human cytochrome P450 enzymes in estrone oxidation.

Authors:  Alastair E Cribb; M Joy Knight; Dagny Dryer; Judy Guernsey; Kimberly Hender; Marvin Tesch; Tarek M Saleh
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-03       Impact factor: 4.254

View more
  31 in total

Review 1.  Influence of berry polyphenols on receptor signaling and cell-death pathways: implications for breast cancer prevention.

Authors:  Harini S Aiyer; Anni M Warri; Denzel R Woode; Leena Hilakivi-Clarke; Robert Clarke
Journal:  J Agric Food Chem       Date:  2012-02-22       Impact factor: 5.279

Review 2.  Pharmacological Modulation of Lung Carcinogenesis in Smokers: Preclinical and Clinical Evidence.

Authors:  Silvio De Flora; Gancho Ganchev; Marietta Iltcheva; Sebastiano La Maestra; Rosanna T Micale; Vernon E Steele; Roumen Balansky
Journal:  Trends Pharmacol Sci       Date:  2015-12-23       Impact factor: 14.819

Review 3.  Food-based natural products for cancer management: Is the whole greater than the sum of the parts?

Authors:  Suleman S Hussain; Addanki P Kumar; Rita Ghosh
Journal:  Semin Cancer Biol       Date:  2016-07-07       Impact factor: 15.707

4.  Chemoprevention of oral cancer by topical application of black raspberries on high at-risk mucosa.

Authors:  Blake M Warner; Bruce C Casto; Thomas J Knobloch; Brent T Accurso; Christopher M Weghorst
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2014-09-16

5.  Associations between Dietary Intake of Fruits and Vegetables in relation to Urinary Estrogen DNA Adduct Ratio.

Authors:  Kerryn W Reding; Muhammad Zahid; Ercole Cavalieri; Eleanor G Rogan; Brianne S Raccor; Charlotte Atkinson; Mellissa Yong; Katherine M Newton; Johanna W Lampe
Journal:  Open J Prev Med       Date:  2014-06

6.  Effects of Black Raspberries and Their Constituents on Rat Prostate Carcinogenesis and Human Prostate Cancer Cell Growth In Vitro.

Authors:  Jillian N Eskra; Alaina Dodge; Michael J Schlicht; Maarten C Bosland
Journal:  Nutr Cancer       Date:  2019-08-12       Impact factor: 2.900

7.  Antioxidant and antiproliferative activities of anthocyanin/ellagitannin-enriched extracts from Syzygium cumini L. (Jamun, the Indian Blackberry).

Authors:  Farrukh Aqil; Akash Gupta; Radha Munagala; Jeyaprakash Jeyabalan; Hina Kausar; Ram Jee Sharma; Inder Pal Singh; Ramesh C Gupta
Journal:  Nutr Cancer       Date:  2012-03-16       Impact factor: 2.900

Review 8.  Role of dietary bioactive natural products in estrogen receptor-positive breast cancer.

Authors:  Min Ji Bak; Soumyasri Das Gupta; Joseph Wahler; Nanjoo Suh
Journal:  Semin Cancer Biol       Date:  2016-03-22       Impact factor: 15.707

9.  Dietary γ-Tocopherol-Rich Mixture Inhibits Estrogen-Induced Mammary Tumorigenesis by Modulating Estrogen Metabolism, Antioxidant Response, and PPARγ.

Authors:  Soumyasri Das Gupta; Sudathip Sae-tan; Joseph Wahler; Jae Young So; Min Ji Bak; Larry C Cheng; Mao-Jung Lee; Yong Lin; Weichung Joe Shih; James D Shull; Stephen Safe; Chung S Yang; Nanjoo Suh
Journal:  Cancer Prev Res (Phila)       Date:  2015-06-30

10.  Urolithin A suppresses the proliferation of endometrial cancer cells by mediating estrogen receptor-α-dependent gene expression.

Authors:  Wei Zhang; Jo-Hsin Chen; Irene Aguilera-Barrantes; Chung-Wai Shiau; Xiugui Sheng; Li-Shu Wang; Gary D Stoner; Yi-Wen Huang
Journal:  Mol Nutr Food Res       Date:  2016-07-25       Impact factor: 5.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.